安旭生物收盘上涨1.20%，滚动市盈率23.54倍，总市值47.34亿元

金融界2025-04-22

4月22日，安旭生物今日收盘37.25元，上涨1.20%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到23.54倍，创13天以来新低，总市值47.34亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.08倍，行业中值30.21倍，安旭生物排名第56位。截至2024年三季报，共有1家机构持仓安旭生物，其中基金1家，合计持股数16.47万股，持股市值0.07亿元。杭州...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529371506?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-22 18:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529371506","market":"us","top_or_hot":-1,"title":"安旭生物收盘上涨1.20%，滚动市盈率23.54倍，总市值47.34亿元","media":"金融界","content":"<div>\n<p>4月22日，安旭生物今日收盘37.25元，上涨1.20%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到23.54倍，创13天以来新低，总市值47.34亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.08倍，行业中值30.21倍，安旭生物排名第56位。截至2024年三季报，共有1家机构持仓安旭生物，其中基金1家，合计持股数16.47万股，持股市值0.07亿元。杭州...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/04/22185349761015.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>安旭生物收盘上涨1.20%，滚动市盈率23.54倍，总市值47.34亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n安旭生物收盘上涨1.20%，滚动市盈率23.54倍，总市值47.34亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-22 18:53 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/04/22185349761015.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月22日，安旭生物今日收盘37.25元，上涨1.20%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到23.54倍，创13天以来新低，总市值47.34亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.08倍，行业中值30.21倍，安旭生物排名第56位。截至2024年三季报，共有1家机构持仓安旭生物，其中基金1家，合计持股数16.47万股，持股市值0.07亿元。杭州...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/04/22185349761015.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688075","symbol_name":"安旭生物","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/04/22185349761015.shtml","article_id":"2529371506","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529371506","pubTimestamp":1745319232,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"4月22日，安旭生物今日收盘37.25元，上涨1.20%，滚动市盈率PE达到23.54倍，创13天以来新低，总市值47.34亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.08倍，行业中值30.21倍，安旭生物排名第56位。截至2024年三季报，共有1家机构持仓安旭生物，其中基金1家，合计持股数16.47万股，持股市值0.07亿元。最新一期业绩显示，2024年三季报，公司实现营业收入4.03亿元，同比27.56%；净利润1.36亿元，同比-27.33%，销售毛利率42.11%。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688075":"安旭生物","BK0239":"医药制造"},"translate_title":"Anxu Bio closed up 1.20%, with a rolling P/E of 23.54 times, and a total market value of 4.734 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688075":1},"content_text":"4月22日，安旭生物今日收盘37.25元，上涨1.20%，滚动市盈率PE（当前股价与前四季度每股收益总和的比值）达到23.54倍，创13天以来新低，总市值47.34亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.08倍，行业中值30.21倍，安旭生物排名第56位。截至2024年三季报，共有1家机构持仓安旭生物，其中基金1家，合计持股数16.47万股，持股市值0.07亿元。杭州安旭生物科技股份有限公司专注于POCT试剂及仪器的研发、生产与销售。公司主要产品为POCT试剂及仪器。公司拥有抗原抗体自主研发生产的生物原料技术平台，以及成熟的免疫层析及干式生化诊断技术平台，发展形成了覆盖毒品检测、传染病检测、慢性病检测、妊娠检测、肿瘤检测、心肌检测、生化检测、过敏原检测八大领域的POCT试剂，产品远销美国、德国、英国、加拿大、俄罗斯、墨西哥、泰国、印尼及波兰等150多个国家，已成为国内少数几家在POCT国际市场能够与跨国体外诊断行业巨头竞争的中国体外诊断产品供应商之一。最新一期业绩显示，2024年三季报，公司实现营业收入4.03亿元，同比27.56%；净利润1.36亿元，同比-27.33%，销售毛利率42.11%。序号股票简称PE(TTM)PE(静)市净率总市值(元)56安旭生物23.5423.540.9247.34亿行业平均48.0850.954.83103.18亿行业中值30.2131.172.3544.33亿1天益医疗-2739.91-2739.911.7220.38亿2硕世生物-1894.86-1894.861.1737.93亿3诺唯赞-517.67-517.672.3793.67亿4澳华内镜-515.47258.534.1354.32亿5博晖创新-353.40-217.583.8954.24亿6康泰医学-265.4831.152.7151.63亿7华大基因-197.23215.742.04200.43亿8奥精医疗-123.37-123.371.5722.35亿9热景生物-72.80-72.804.00130.48亿10睿昂基因-72.39-72.391.2611.41亿11华大智造-55.13-55.134.14330.30亿","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529371506","isCrawlerRequest":true}